TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive In Brief: Cancer Control To Push Environmental Research Occupational Hazards; Bailer to Journal Post May 24, 1974
TCL Archive House Appropriations Adds $20 Mil. To Bush Request For NCI, Emphasizes Three Cancers June 28, 1991
